Hanne Bødtcher

Hanne Bødtcher

Auto-generated profile, based on publicly available information

Hanne Bødtcher

Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in Acta Oncologica
Verified
Journal Article
Closed access
EKEva Kjeldsted
Eva Kjeldsted
KLKatrine Vammen Lindblad
Katrine Vammen Lindblad
HBHanne Bødtcher
Hanne Bødtcher
DSDina Melanie Sørensen
Dina Melanie Sørensen
ERElizabeth Rosted
Elizabeth Rosted
SDSusanne Oksbjerg Dalton
Susanne Oksbjerg Dalton
During the COVID-19 pandemic, teleconsultations (TC) have been increasingly used in cancer care as an alternative to outpatient visits. We aimed to examine patient-related and cancer-specific chara...

15 October 2022 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
HBHanne Bødtcher
Hanne Bødtcher
KLKatrine Vammen Lindblad
Katrine Vammen Lindblad
DSDina Melanie Sørensen
Dina Melanie Sørensen
ERElizabeth Rosted
Elizabeth Rosted
EKEva Kjeldsted
Eva Kjeldsted
SDSusanne Oksbjerg Dalton
Susanne Oksbjerg Dalton
Purpose: During the COVID-19 pandemic, teleconsultations have increasingly been used to reduce physical contact and thus risk of infection. This study investigated how patients with cancer experienced the COVID-19 pandemic and how they perceived the change from in-person consultations to telephone consultations in an oncology outpatient clinic. The aim was to provide insights that could optimize the future use of teleconsultations in cancer care. Methods: This qualitative study included 15 patients with colorectal, breast, gynecological, lung, or prostate cancer treated at the outpatient clinic at the Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark in June or July 2020. Data were collected through semi-structured individual interviews and analyzed by thematic analysis. Results: Patients with cancer experienced social, psychological, and organizational consequences of the COVID-19 pandemic related to their cancer care. Not all patients were comfortable with telephone consultations. Six themes were identified: (1) double burden as a consequence of simultaneous cancer and the COVID-19 pandemic, (2) parameters for patient satisfaction with telephone consultations, (3) the importance of relatives attending consultations, (4) loss of information and nuances during telephone consultations, (5) the impact of physicians’ language and communicative skills during telephone consultations, and (6) patients’ suggestions for future telephone consultations. Conclusion: Beyond the COVID-19 pandemic, it is important that hospitals offering teleconsultations involve patients’ preferences, consider for which patients and consultations the solution is suitable, which technology to use, how to prepare patients and relatives, and how to provide physicians with the necessary communicative skills.

30 October 2025 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
KNKristina Holmegaard Nørskov
Kristina Holmegaard Nørskov
HBHanne Bødtcher
Hanne Bødtcher
TRTine Rosenberg
Tine Rosenberg
CDCamilla Thim Damgaard
Camilla Thim Damgaard
INIben Husted Nielsen
Iben Husted Nielsen
SDSusanne Oksbjerg Dalton
Susanne Oksbjerg Dalton
Purpose: To investigate the extent and practice of home-based treatment for patients with hematologic malignancies in Denmark. Methods: This nationwide exploratory study was conducted at all Danish hematologic departments ( n = 9). Each site received an online questionnaire for the collection of data on the type of therapy administered as home-based treatment, the specific treatments with details on target populations, patient criteria, implementation status, and practice for clinical management. Results: Six types of therapy were offered as home-based treatments across the Danish hematologic departments: chemotherapy, immunoglobulin, immunotherapy, hydration therapy, antibiotics, and parenteral nutrition. In total, 17 treatments were offered, with the majority being provided to patients with multiple myeloma. Immunoglobulin and antibiotics were most often provided at home. Variations were identified regarding patient criteria for receiving home-based treatment, including personal resources and social networks, use of intravenous accesses and infusion pumps, and timing of initiation of home-based treatment. Conclusion: There is variation in the implementation of home-based treatment for patients with hematologic malignancies in Denmark, including different criteria and practices. To fully realize the benefits of home-based treatment, it is imperative to address access disparities, standardize practices, and enhance support for patients and caregivers. Continued research, collaboration, and policy development are essential to ensure that all patients have equitable access to high-quality home-based treatment options.

1 January 2024 in Digital Health
Verified
Journal Article
Open access
KLKatrine Vammen Lindblad
Katrine Vammen Lindblad
HBHanne Bødtcher
Hanne Bødtcher
DSDina Melanie Sørensen
Dina Melanie Sørensen
ERElizabeth Rosted
Elizabeth Rosted
EKEva Kjeldsted
Eva Kjeldsted
SDSusanne Oksbjerg Dalton
Susanne Oksbjerg Dalton
Objective: During the COVID-19 pandemic, changes were made in cancer care including increased use of teleconsultations (TCs) and restrictions for relatives to attend in-person appointments at the outpatient clinics. This study aimed to provide in-depth information on healthcare professionals’ experiences of TC and the limited access for relatives during the COVID-19 pandemic in 2020. Methods: This qualitative study was conducted at an oncological department responsible for oncological care of all patients with cancer in one of five health regions in Denmark. Fourteen healthcare professionals participated in three semi-structured focus group interviews with either secretaries and nurses or physicians, and one semi-structured individual interview with a secretary. Data were analyzed by thematic analysis. Results: Four overall themes emerged in the thematic analysis: “Possibilities and limitations in relation to TC,” “Information load and timing,” “Insecurity” and “Lessons learned for the future.” Healthcare professionals missed face-to-face interactions, feared to overlook patients’ symptoms and relapse during TC, agreed that TC were not suitable for all types of consultations, and experienced improved work environment due to fewer patients and relatives at the department. Furthermore, patients should be involved in the decision of changing to TC, relatives must be recommended to participate in TC, physicians must meet the patient in-person before TC, and video consultations should be considered. Conclusion: TC may be a valuable supplement to in-person consultations for patients with cancer in the future, and guidelines must be implemented to ensure suitable consultation types for TC, include patients’ preferences, and involve relatives.

25 February 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
BKBen Kinnersley
Ben Kinnersley
PBPeter Broderick
Peter Broderick
DCDaniel Chubb
Daniel Chubb
HBHanne Bødtcher
Hanne Bødtcher
KLKarim Labreche
Karim Labreche
Richard HoulstonRichard Houlston
Richard Houlston
The genetic aetiology of familial glioma is largely unknown. To gain further insight into the role of rare disruptive variants we performed whole exome sequencing (WES) of 17 glioma families, identifying two families where loss of function mutations in dynein axonemal heavy chain 11 (DNAH11) co-segregated with glioma (DNAH11 p.Ser1470ArgfsTer6 and p.Thr3900Lys) and single families implicating Telomere Replication Complex Component 1 (CTC1 p.Leu1058ProfsTer32) and filamin alpha (FLNA p.Ser1356Phe). We complemented linkage analysis by WES of 150 additional unrelated familial glioma cases and conducting gene burden tests leveraging WES data on 691 cases of glioma from TCGA. Our analysis does not provide support for a hitherto unidentified major cancer gene for glioma but highlights a series of novel candidate predisposition variants/genes, worthy of further investigation to shed light on glioma risk.

29 October 2026 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
HBHanne Bødtcher
Hanne Bødtcher
SASarah Auener
Sarah Auener
KNKristina Holmegaard Nørskov
Kristina Holmegaard Nørskov
INIben Husted Nielsen
Iben Husted Nielsen
SDSusanne Oksbjerg Dalton
Susanne Oksbjerg Dalton